The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Stibbe

CENTRAL PLAZA, LOKSUMSTRAAT 25/ RUE DE LOXUM 25, 1000 BRUSSELS, BELGIUM
Tel:
Work +32 2 533 52 11
Fax:
Fax +32 2 533 52 12
DX:
36 BAB
Email:
Web:
www.stibbe.com
Amsterdam, Brussels, Dubai, London, Luxembourg, New York

Manuel Campolini

Tel:
Work +32 2 533 53 60
Email:
Web:
stibbe.com
Stibbe

Work Department

Intellectual Property, Life Sciences, Pharmaceuticals

Position

Of Counsel

Career

Manuel Campolini focuses his practice on legal assistance, advice and litigation in relation to life sciences and pharmaceutical issues (IP, regulatory, biotechnology, pricing, clinical trials, parallel trade, advertising etc.), on a national as well as European level. He has extensive experience in the life-cycle management strategy of pharmaceutical products. He regularly advises and represents companies before the EU authorities, especially before the EU Commission.
As a specialist in EU pharmaceutical law, Manuel Campolini is a frequent public speaker on his areas of competence.
Manuel Campolini is a professor at the Haute Ecole Léonard de Vinci (ILMH).

Languages

French, English, Italian

Member

Manuel is member of the editorial board of Patent World and of Regulatory Affairs Journal – Pharma. Furthermore and of the International Association for the Protection of Intellectual Property (AIPPI) and of LES.

Education

Manuel graduated in law from the Université de Liège (1980). He holds a Degree in European law from the ULg (1981).


Belgium

Industry focus: Healthcare and life sciences

Within: Industry focus: Healthcare and life sciences

Stibbe's broad expertise spans the pharmaceutical, biotechnology, life sciences, healthcare and medical device sectors. It has considerable IP and regulatory experience, as well as the ability to leverage the firm's wider full service capabilities in other areas. A team led by practice head Ignace Vernimme is representing Celltrion in patent infringement claims brought by Roche, Genentech, and Biogen relating to the client's biosimilar product, Truxima. In another work highlight, the department is acting for Perrigo in an arbitration concerning fraud and breach of warranties brought against the former owner of the company, Omega Pharma Invest. Of counsel Manuel Campolini is also highlighted for his litigation and regulatory capabilities.

[back to top]


Back to index

Legal Developments in Belgium

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to